The treatment of hepatic encephalopathy (Q36936857)

17 August 2017

1 reference

title

The treatment of hepatic encephalopathy (English)

1 reference

17 August 2017

Marsha Y Morgan

1

1 reference

17 August 2017

A Blei

2

1 reference

17 August 2017

K Grüngreiff

3

1 reference

17 August 2017

R Jalan

4

1 reference

17 August 2017

G Kircheis

5

1 reference

17 August 2017

G Marchesini

6

1 reference

17 August 2017

O Riggio

7

1 reference

17 August 2017

Karin Weissenborn

8

1 reference

17 August 2017

publication date

1 December 2007

1 reference

17 August 2017

published in

Metabolic Brain Disease

1 reference

17 August 2017

volume

22

1 reference

17 August 2017

issue

3-4

1 reference

17 August 2017

page(s)

389-405

1 reference

Effects of L-carnitine in patients with hepatic encephalopathy

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11011-007-9060-7

Dispelling myths in the treatment of hepatic encephalopathy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11011-007-9060-7

Reliability of urinary tests for antibody to Helicobacter pylori in patients with pulmonary tuberculosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11011-007-9060-7

Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis

21 January 2018

1 reference

12 December 2020

[Clinical aspects of acute liver insufficiency.]

1 reference

12 December 2020

Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy

1 reference

12 December 2020

Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial

1 reference

12 December 2020

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

1 reference

12 December 2020

Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts

1 reference

12 December 2020

Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial

1 reference

12 December 2020

Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy

1 reference

12 December 2020

Treatment of hepatic encephalopathy

1 reference

12 December 2020

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

1 reference

12 December 2020

Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial

1 reference

12 December 2020

Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis

1 reference

12 December 2020

[Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study]

1 reference

12 December 2020

Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells

1 reference

12 December 2020

Bromocriptine-associated hyponatraemia in cirrhosis.

1 reference

12 December 2020

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

1 reference

12 December 2020

Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat.

1 reference

12 December 2020

Experimental zinc deficiency in humans

1 reference

12 December 2020

Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial

1 reference

12 December 2020

Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial

1 reference

12 December 2020

Review article: the current pharmacological therapies for hepatic encephalopathy

1 reference

12 December 2020

Infection, inflammation and hepatic encephalopathy, synergism redefined

1 reference

12 December 2020

Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats

1 reference

12 December 2020

Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid

1 reference

12 December 2020

Overt hepatic encephalopathy precipitated by zinc deficiency

1 reference

12 December 2020

Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy

1 reference

12 December 2020

Intestinal microflora in patients with alcoholic cirrhosis: urea-splitting bacteria and neomycin resistance.

1 reference

12 December 2020

New mode of action for lactulose

1 reference

12 December 2020

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

1 reference

12 December 2020

Treatment of chronic portal-systemic encephalopathy with lactulose

1 reference

12 December 2020

TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS.

1 reference

12 December 2020

Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis

1 reference

12 December 2020

[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial]

1 reference

12 December 2020

Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy

1 reference

12 December 2020

Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis

1 reference

12 December 2020

Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase

1 reference

12 December 2020

L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy

1 reference

12 December 2020

Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design

1 reference

12 December 2020

The role of carnitine supplementation during valproic acid therapy

1 reference

12 December 2020

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

1 reference

12 December 2020

Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

1 reference

12 December 2020

Hyperammonemia related to carnitine metabolism with particular emphasis on ornithine transcarbamylase deficiency

1 reference

12 December 2020

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

1 reference

12 December 2020

Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.

1 reference

12 December 2020

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

1 reference

12 December 2020

1 reference

12 December 2020

Endotoxinemia and benzodiazepine-like substances in compensated cirrhotic patients: a randomized study comparing the effect of rifaximine alone and in association with a symbiotic preparation

1 reference

12 December 2020

The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis

1 reference

12 December 2020

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

1 reference

12 December 2020

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

1 reference

12 December 2020

Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy

1 reference

12 December 2020

Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis

1 reference

12 December 2020

Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease

1 reference

12 December 2020

Role of ammonia and inflammation in minimal hepatic encephalopathy

1 reference

12 December 2020

Bromocriptine-associated ototoxicity

1 reference

12 December 2020

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

1 reference

12 December 2020

Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.

1 reference

12 December 2020

Therapy of severe hyperammonemia

1 reference

12 December 2020

Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial

1 reference

12 December 2020

Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo

1 reference

12 December 2020

Ammonia metabolism and hepatic encephalopathy

1 reference

12 December 2020

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study

1 reference

12 December 2020

Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial

1 reference

12 December 2020

Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo.

1 reference

12 December 2020

Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy

1 reference

12 December 2020

Correlations between zinc, amino acids and ammonia in liver cirrhosis

1 reference

12 December 2020

10.1007/S11011-007-9060-7

Identifiers

DOI

1 reference

17 August 2017

1 reference